Search
for
Sort by
Research 61–90 of 1000+
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Topically used herbal products for the treatment of hair loss: preclinical and clinical studies
- Steroid Hormones
- Finasteride, A Steroid 5α-Reductase Inhibitor, Does Not Affect the Oxidative Metabolism of Antipyrine
- Adrenal steroid precursors exert potent androgenic action in the hamster sebaceous glands of flank organs and ears.
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Isolation and Structural Characterization of Finasteride Degradation Products by Preparative HPLC, HRMS, and NMR
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Bioequivalence Study of Finasteride
- Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors
- A systematic study of determination and validation of finasteride impurities using liquid chromatography
- Treatment of Hair Loss
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Chapter 23. Therapeutic Control of Androgen Action
- Clinical Case Notes. Retinoblastoma, microphthalmia and the chromosome 13q deletion syndrome
- Clinical Research Progress on Plum-Blossom Needle Combined Therapy for Androgenic Alopecia
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Finasteride and androgenic alopecia; from therapeutic options to medical implications
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
- Finasteride: the first 5 alpha-reductase inhibitor.